InvestorsHub Logo
Followers 603
Posts 24107
Boards Moderated 3
Alias Born 12/06/2009

Re: None

Monday, 05/18/2020 7:13:56 AM

Monday, May 18, 2020 7:13:56 AM

Post# of 27659
$MYMX CoVid-19 NEWS Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
ACCESSWIRE FOLLOW

Mymetics has started a Covid-19 vaccine development project based on Mymetics' virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine
Baylor College of Medicine in Texas has developed SARS-CoV and SARS-CoV-2 recombinant proteins and has extensive expertise developing protein-based vaccines from discovery through clinical testing
Baylor and Mymetics will collaborate to evaluate the Baylor SARS recombinant protein antigens linked to Mymetics' virisomes in preclinical studies with the aim to identify and select the most efficacious and safe formulations to take forward a virosome-based COVID-19 vaccine through product and clinical development


https://www.mymetics.com/media-center/mymetics/

https://www.benzinga.com/pressreleases/20/05/ac16053140/mymetics-and-baylor-college-of-medicine-start-research-collaboration-for-virosome-based-covid-19-?utm_campaign=Watchlist&utm_source=Benzinga&utm_medium=Email
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News